Stay updated on Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision history updated to include v3.4.3 and remove v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-07T08:40:12.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2; this is a minor maintenance update with no visible changes to study data or navigation, and to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T17:35:01.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1 on the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-06T11:28:24.000Z thumbnail image
  6. Check
    53 days ago
    Change Detected
    Summary
    UI text updates include glossary toggle options ('Show glossary' and 'Hide glossary') and capitalization tweaks to QC-related labels (e.g., No FEAR Act Data). The page revision was updated to v3.4.0.
    Difference
    0.1%
    Check dated 2026-01-23T06:20:18.000Z thumbnail image
  7. Check
    60 days ago
    Change Detected
    Summary
    Revision tag updated from v3.3.3 to v3.3.4 on the page. This is a routine version label change.
    Difference
    0.0%
    Check dated 2026-01-16T04:47:02.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    A centralized Locations section was added, enumerating study sites across many countries, and several regional location blocks were removed.
    Difference
    2%
    Check dated 2025-12-17T17:52:41.000Z thumbnail image

Stay in the know with updates to Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab + Ipilimumab vs. Placebo in NSCLC Clinical Trial page.